6 minute read

Jan. 19, 2024

Targeting Post-Transcriptional RNA-Modification with a First-to-Clinic METTL3 Inhibitor: STC15

Author:

Shaima Qunies

Editors:

Yan Chen,

Dennis X. Hu

Other articles you may be interested in